Polymorphisms in the AR and PSA Genes as Markers of Susceptibility and Aggressiveness in Prostate Cancer

REFERENCES

• INCA. Estimativa de câncer 2009 2008. Retrieved June 16, 2009, from http://www.inca.gov.br.
   Google Scholar
• Chan, J.M.; Gann, P.H.; Giovannucci, E.L. Role of diet in prostate cancer development and progression. J Clin Oncol 2005, 23, 8152–8160.
   PubMed Web of Science ®Google Scholar
• Ferreira, C.G.; Rocha, J.C. Oncologia Molecular. 1a Edição: Editora Atheneu, 2004.
   Google Scholar
• Carter, B.S.; Beaty, T.H.; Steinberg, G.D.; Childs, P.C. Mendelian inheritance of familial prostate cancer. PNAS 1992, 89, 3367–3371.
   PubMed Web of Science ®Google Scholar
• Sieh, W.; Edwards, K.L.; Fitzpatrick, A.L. Genetic susceptibility to prostate cancer: prostate-specific antigen and its interaction with the androgen receptor. Cancer Causes Control 2006, 17(2), 187–197.
   PubMed Web of Science ®Google Scholar
• Lai, J.; Kedda, M.A.; Hinze, R.L.; Smith, J.; Yaxley, A.B.; Spurdle, C.P.; Morris, J.; Harris, J.A. Clements PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility. Carcinogenesis 2007, 28(5), 1032–1039.
   PubMed Web of Science ®Google Scholar
• Giovanucci, E.; Stampfer, M.J.; Krithivas, K.; Brown, M.; Dahl, D.; Brufsky, A. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. PNAS 1997, 94, 3320–3323.
   PubMed Web of Science ®Google Scholar
• Santos, M.L.; Sarkis, A.S.; Nishimoto, I.N.; Nagai, M.A. Androgen receptor CAG repeat polymorphism in prostate cancer from a Brazilian population. Cancer Detect Prev 2003, 27, 321–326.
   PubMedGoogle Scholar
• Wang, Q.; Udayakumar, T.S.; Vasaitis, T.S.; Brodie, A.M.; Fondell, J.D. Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells. J Biol Chem 2004, 279(17), 17319–17328.
   PubMed Web of Science ®Google Scholar
• Platz, E.A.; Leitzmann, M.F.; Rifai, N.; Kantoff, P.W.; Chen, Y.C.; Stampfer, M.J.; Willett, W.C.; Giovannucci, E. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. Cancer Epidemiol Biomarkers Prev 2005, 14(5), 1262–1269.
   PubMed Web of Science ®Google Scholar
• Hakimi, J.M.; Schoenberg, M.P.; Rondinelli, R.H.; Piantadosi, S.; Barrack, E.R. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer. Clin Cancer Res 1997, 3, 1599–1608.
   PubMed Web of Science ®Google Scholar
• Levine, D.A.; Boyd, J. The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series. Cancer Res 2001, 61(3), 908–911.
   PubMed Web of Science ®Google Scholar
• Rodríguez, G.; Bilbao, C.; Ramírez, R.; Falcón, O.; León, L.; Chirino, R.; Falcón, O. Jr.; Díaz, B.P.; Rivero, J.F.; Perucho, M.; Díaz-Chico, B.N.; Díaz-Chico, J.C. Alleles with short CAG and GGN repeats in the androgen receptor gene are associated with benign endometrial cancer. Int J Cancer 2006, 118(6), 1420–1425.
   PubMed Web of Science ®Google Scholar
• Wu, M.H.; Chou, Y.C.; Yu, C.P.; Yang, T.; You, S.L.; Chen, C.J.; Sun, C.A. Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility. Eur J Cancer Prev 2008, 17(4), 317–322.
   PubMed Web of Science ®Google Scholar
• Balk, S.P.; Ko, Y.J.; Bubley, G.J. Biology of prostate-specific antigen. J Clin Oncol 2003, 21, 383–391.
   PubMed Web of Science ®Google Scholar
• Xue, W.; Irvine, R.A.; Yu, M.C.; Ross, R.K.; Coetzee, G.A.; Ingles, S.A. Susceptibility to prostate cancer: interaction between genotypes at the androgen receptor and prostate-specific antigen loci. Cancer Res 2000, 60(4), 839–841.
   PubMed Web of Science ®Google Scholar
• Gsur, A.; Preyer, A.; Haidinger, G.; Zidek, T.; Madersbacher, S.; Schatzl, G.; Marberger, M.; Vutuc, C.; Mickschel, M. Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk. Carcinogenesis 2002, 23(10), 1647–1651.
   PubMed Web of Science ®Google Scholar
• Binnie, M.C.; Alexander, F.E.; Heald, C.; Habib, F.K. Polymorphic forms of prostate specific antigen and their interaction with androgen receptor trinucleotide repeats in prostate cancer. Prostate 2005, 63(4), 309–315.
   PubMed Web of Science ®Google Scholar
• Schoenberg, M.P.; Hakimi, J.M.; Wang, S. Microsatellite mutation (CAG24->18) in the androgen receptor gene in human prostate cancer. Biochem Biophys Res Commun 1994, 198(1), 74–80.
   PubMed Web of Science ®Google Scholar
• Tsujimoto, Y.; Takakuwa, T.; Takayama, H.; Nishimura, K.; Okuyama, A.; Aozasa, K.; Nonomura, N. In situ shortening of CAG repeat length within the androgen receptor gene in prostatic cancer and its possible precursors. Prostate 2004, 58(3), 283–290.
   PubMed Web of Science ®Google Scholar
• Santos, R.M.; Jesus, C.M.; Trindade Filho, J.C.; Camargo, J.L.; Rainho, C.A.; Rogatto, S.R. PSA and androgen-related gene (AR, CYP17, and CYP19) polymorphisms and the risk of adenocarcinoma at prostate biopsy. DNA Cell Biol 2008, 27(9), 497–503.
   PubMed Web of Science ®Google Scholar
• Alvarado, C.; Beitel, L.K.; Sircar, K.; Aprikian, A.; Trifiro, M.; Gottlieb, B. Somatic mosaicism and cancer: a micro-genetic examination into the role of the androgen receptor gene in prostate cancer. Cancer Res 2005, 65(18), 8514–8518.
   PubMed Web of Science ®Google Scholar
• Carrano, A.V.; Natarajana, A.T. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication no. 14. Considerations for population monitoring using cytogenetic techniques. Mutat Res 1988, 204,379–406.
   PubMed Web of Science ®Google Scholar
• Miller, S.A.; Dykes, D.D.; Polesky, H.F. A simple salting out procedure for extraction DNA from human nucleated cell. Nucleic Acids Res 1988, 16, 1215.
   PubMed Web of Science ®Google Scholar
• Bharaj, B.S.; Vassilikos, E.J.; Diamandis, E.P. Rapid and accurate determination of (CAG)n repeats in the androgen receptor gene using polymerase chain reaction and automated fragment analysis. Clin Biochem 1999, 32(5), 327–332.
   PubMed Web of Science ®Google Scholar
• Ribeiro, M.L.; Santos, A.; Carvalho-Salles, A.B.; Hackel, C. Allelic frequencies of six polymorphic markers for risk of prostate cancer. Braz J Med Biol Res 2002, 35(2), 205–213.
   PubMed Web of Science ®Google Scholar
• Gleason, D.F. Histologic grading of prostate cancer: a perspective. Human Pathol 1992, 23, 273–279.
   PubMed Web of Science ®Google Scholar
• American Joint Committee on Cancer/ International Union Against Cancer (AJCC/UICC). TMN Classification. 2009. Retrieved June 6, 2009, from http://www.uicc.org.
   Google Scholar
• D’Amico, A.V.; Whittington, R.; Malkowicz, S.B.; Ondurulia, J.; Chen, M.H.; Tomaszewski, J.E. The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer. J Urol 1998, 160(6 Pt 1), 2096–2101.
   PubMed Web of Science ®Google Scholar
• Ayres, M.; Ayres, M. Jr.; Ayres, D.L., Santos, A.S.; BioEstat Version.5. Pará, Brazil: Civil Society MCT Mamirauá – CNPq.
   Google Scholar
• Braile, D.M.; Godoy, M.F. Odds Ratio Calculator. São Paulo, Brazil: Braile Biomedics.
   Google Scholar
• Sanchez, D.; Rosell, D.; Honorato, B.; Lopez, J.; Arocena, J.; Sanz, G. Androgen receptor mutations are associated with Gleason score in localized prostate cancer. Br J Urol Int 2006, 98(6), 1320–1325.
   Google Scholar
• Mir, K.; Edwards, J.; Paterson, P.J.; Hehir, M.; Underwood, M.A.; Bartlett, J.M. The CAG trinucleotide repeat length in the androgen receptor does not predict the early onset of prostate cancer. Br J Urol Int 2002, 90(6), 573–578.
   Google Scholar
• Coughlin, S.S.; Hall, I.J. A review of genetic polymorphisms and prostate cancer risk. Ann Epidemiol 2002, 12(3), 182–196.
   PubMed Web of Science ®Google Scholar
• Han, M.; Gann, P.H.; Catalona, W.J. Prostate-specific antigen and screening for prostate cancer. Med Clin North Am 2004, 88(2), 245–265.
   PubMed Web of Science ®Google Scholar
• Catalona, W.J.; Loeb, S. The PSA era is not over for prostate cancer. Eur Urol 2005, 48(4), 541–545.
   PubMed Web of Science ®Google Scholar
• Marcella, S.W.; Rhoads G.G.; Carson, J.L.; Merlino, F.; Wilcox, H. Prostate-specific antigen screening and mortality from prostate cancer. J Gen Intern Med 2008, 23(3), 248–253.
   PubMed Web of Science ®Google Scholar
• Dubey, D. The routine use of prostate-specific antigen for early detection of cancer prostate in India: is it justified? Indian J Urol 2009, 25(2), 177–184.
   PubMedGoogle Scholar
• Cramer, S.D.; Chang, B.L.; Rao, A.; Hawkins, G.A.; Zheng, S.L.; Wade, W.N.; Cooke, R.T.; Thomas, L.N.; Bleecker, E.R.; Catalona, W.J.; Sterling, D.A.; Meyers, D.A.; Ohar, J.; Xu, J. Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels. J Nat Cancer Inst 2003, 95(14), 1044–1053.
   PubMed Web of Science ®Google Scholar
• Chiang, C.H.; Chen, K.K.; Chang, L.S.; Hong, C.J. The impact of polymorphism on prostate specific antigen gene on the risk, tumor volume and pathological stage of prostate cancer. J Urol 2004, 171(4), 1529–1532.
   PubMed Web of Science ®Google Scholar
• Jesser, C.; Mucci, L.; Farmer, D.; Moon, C.; Li, H.; Gaziano, J.M.; Stampfer, M.; Ma, J.; Kantoff, P. Effects of G/A polymorphism, rs266882, in the androgen response element 1 of the PSA gene on prostate cancer risk, survival and circulating PSA levels. Br J Cancer 2008, 99(10), 1743–1747.
   PubMed Web of Science ®Google Scholar
• Sadar, M.D.; Hussain, M.; Bruchovsky, N. Prostate cancer: molecular biology of early progression to androgen independence. Endocr-Relat Cancer 1999, 6(4), 487–502.
   PubMed Web of Science ®Google Scholar
• Ding, D.; Xu, L.; Menon, M.; Reddy, G.P.; Barrack, E.R. Effect of a short CAG (glutamine) repeat on human androgen receptor function. Prostate 2004, 58(1), 23–32.
   PubMed Web of Science ®Google Scholar
• Stanford, J.L.; Just, J.J.; Gibbs, M. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 1997, 57, 1194.
   PubMed Web of Science ®Google Scholar
• Hsing, A.W.; Chokkalingam, A.P. Prostate cancer epidemiology. Front Biosci 2006, 11, 1388–1413.
   PubMed Web of Science ®Google Scholar
• Zeegers, M.P.; Kiemeney, L.A.; Nieder, A.M.; Ostrer, H. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk? Cancer Epidemiol Biomarkers Prev 2004, 13(11), 1765–1771.
   PubMed Web of Science ®Google Scholar
• Sartor, O.; Zheng, Q.; Eastham, J.A. Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer. Urology 1999, 53, 378–380.
   PubMed Web of Science ®Google Scholar
• Price, D.K.; Franks, M.E.; Figg, W.D. Genetic variations in the vitamin D receptor, androgen receptor and enzymes that regulate androgen metabolism. J Urol 2004, 171(2), 45–49.
   Google Scholar
• Culpi, L.; Salzano, F.M. Migration, genetic markers and race admixture in Curitiba, Brazil. J Biosoc Sci 1984, 16, 127–135.
   PubMed Web of Science ®Google Scholar
• Parra, F.C.; Amado, R.C.; Lambertucci, J.R.; Rocha, J.; Antunes, C.M.; Pena, S.D.J. Color and genomic ancestry in Brazilians. Genetics 2002, 100, 177–182.
   Google Scholar
• Xu, J.; Isaac, S.D.; Wiley, K.E.; Meyers, D.A.; Smith, J.F.; Carpten, J.D.; Trend, J.M. Prostate cancer linkage to HPC1: effect of year of diagnosis. J Urol 2002, 163, 55.
   Google Scholar
• Xue, W.; Coetzee, G.A.; Ross, R.K.; Irvine, R.; Kolonel, L.; Henderson, B.E.; Ingles, S.A. Genetic determinants of serum prostate-specific antigen levels in healthy men from a multiethnic cohort. Cancer Epidemiol Biomarkers Prev 2001, 10(6), 575–579.
   PubMed Web of Science ®Google Scholar
• Schatzl, G.; Marberger, M.; Remzi, M.; Grösser, P.; Unterlechner, J.; Haidinger, G.; Zidek, T.; Preyer, M.; Micksche, M.; Gsur, A. Polymorphism in ARE-I region of prostate-specific antigen gene associated with low serum testosterone level and high-grade prostate cancer. Urology 2005, 65(6), 1141–1145.
   PubMed Web of Science ®Google Scholar
• Hamdy, F.C. Prognostic and predictive factors in prostate cancer. Cancer Treat Rev 2001, 27(3), 143–151.
   PubMed Web of Science ®Google Scholar
• Chatelard, P.P. Standards, options and recommendations for the management of prostate cancer: therapeutic decision criteria. Bull Cancer 2002, 89(6), 619–634.
   PubMed Web of Science ®Google Scholar
• Nelson, C.C.; Hendy, S.C.; Shukin, R.J.; Cheng, H.; Bruchovsky, N.; Koop, B.F.; Rennie, P.S. Determinants of DNA sequence specificity of the androgen, progesterone, and glucocorticoid receptors: evidence for differential steroid receptor response elements. Mol Endocrinol 1999, 13(12), 2090–2107.
   PubMed Web of Science ®Google Scholar
• Yeh, C.C.; Lee, C.; Dahiya, R. DNA mismatch repair enzyme activity and gene expression in prostate cancer. Biochem Biophys Res Commun 2001, 285(2), 409–413.
   PubMed Web of Science ®Google Scholar